EGFR:

Léxane Fournier1, Stefan Becker2, Stefan Zielonka1

  • 1Antibody Discovery and Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany; Biomolecular Immunotherapy, Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.

PubMed
概括

卡梅利德衍生的VHH抗体可以通过调节其全结构来抑制表皮生长因子受体 (EGFR) 信号传递. 计算建模揭示了不同的全模式,指导了新型全生物学的设计.